Literature DB >> 6168636

Studies on human high molecular weight (HMW) kininogen. II. Structural change of HMW kininogen by the action of human plasma kallikrein.

K Mori, S Nagasawa.   

Abstract

We have investigated in detail the cleavage of human high molecular weight (HMW) kininogen by human plasma kallikrein and revealed the formation of a nicked kininogen and a novel kinin-free protein (KFP) as intermediate cleavage products. The cleavage of a single chain HMW kininogen (Mr=120,000) by plasma kallikrein was a three-step reaction. The first cleavage yielded a nicked kininogen composed of two disulfide-linked 62,000 and 56,000 daltons chains. The second cleavage yielded kinin and an intermediate kinin-free protein, KFP-I, which was apparently of equal size to the nicked kininogen. The third cleavage yielded a stable kinin-free protein, KFP-II, composed of two disulfide-linked 62,000 and 45,000 daltons chains. The liberation of an 8,000 daltons fragment was identified when the 56,000 daltons chain isolated by SP-Sephadex C-50 chromatography of reduced and alkylated KFP-I was cleaved by plasma kallikrein into the 45,000 daltons chain. Although the antiserum against HMW kininogen cross-reacted with low molecular weight (LMW) kininogen, the antiserum against the 45,000 daltons chain was specific for HMW kininogen. These results suggest that the antigenic determinant groups common to HMW and LMW kininogens are located in the 62,000 daltons heavy chain, while those specific for HMW kininogen are located in the 45,000 daltons light chain, which is known to retain blood coagulation activity.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6168636     DOI: 10.1093/oxfordjournals.jbchem.a133339

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  11 in total

1.  The sequence HGLGHGHEQQHGLGHGH in the light chain of high molecular weight kininogen serves as a primary structural feature for zinc-dependent binding to an anionic surface.

Authors:  R A DeLa Cadena; R W Colman
Journal:  Protein Sci       Date:  1992-01       Impact factor: 6.725

Review 2.  Bradykinin formation. Plasma and tissue pathways and cellular interactions.

Authors:  A P Kaplan; K Joseph; Y Shibayama; Y Nakazawa; B Ghebrehiwet; S Reddigari; M Silverberg
Journal:  Clin Rev Allergy Immunol       Date:  1998       Impact factor: 8.667

3.  Generation of the bioactive kallikrein-derived fragment, C3d-k, by HANE-plasma.

Authors:  T Seya; S Nagasawa; J P Atkinson
Journal:  Clin Exp Immunol       Date:  1985-10       Impact factor: 4.330

Review 4.  Cross-talk between the complement and the kinin system in vascular permeability.

Authors:  Fleur Bossi; Ellinor I Peerschke; Berhane Ghebrehiwet; Francesco Tedesco
Journal:  Immunol Lett       Date:  2011-07-06       Impact factor: 3.685

5.  Kinetic analysis of the interaction of human tissue kallikrein with single-chain human high and low molecular weight kininogens.

Authors:  M Maier; K F Austen; J Spragg
Journal:  Proc Natl Acad Sci U S A       Date:  1983-07       Impact factor: 11.205

6.  C-terminal ADAMTS-18 fragment induces oxidative platelet fragmentation, dissolves platelet aggregates, and protects against carotid artery occlusion and cerebral stroke.

Authors:  Zongdong Li; Michael A Nardi; Yong-Sheng Li; Wei Zhang; Ruimin Pan; Suying Dang; Herman Yee; David Quartermain; Saran Jonas; Simon Karpatkin
Journal:  Blood       Date:  2009-02-13       Impact factor: 22.113

7.  Cleavage of human high molecular weight kininogen markedly enhances its coagulant activity. Evidence that this molecule exists as a procofactor.

Authors:  C F Scott; L D Silver; M Schapira; R W Colman
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

8.  The inhibition of tube formation in a collagen-fibrinogen, three-dimensional gel by cleaved kininogen (HKa) and HK domain 5 (D5) is dependent on Src family kinases.

Authors:  Yuchuan Liu; Irma M Sainz; Yi Wu; Robin Pixley; Ricardo G Espinola; Sarmina Hassan; Mohammad M Khan; Robert W Colman
Journal:  Exp Cell Res       Date:  2007-10-18       Impact factor: 3.905

9.  The contribution of gC1qR/p33 in infection and inflammation.

Authors:  Ellinor I B Peerschke; Berhane Ghebrehiwet
Journal:  Immunobiology       Date:  2007-01-03       Impact factor: 3.144

10.  Cleavage of kininogen and subsequent bradykinin release by the complement component: mannose-binding lectin-associated serine protease (MASP)-1.

Authors:  József Dobó; Balázs Major; Katalin A Kékesi; István Szabó; Márton Megyeri; Krishnan Hajela; Gábor Juhász; Péter Závodszky; Péter Gál
Journal:  PLoS One       Date:  2011-05-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.